Caboxen 80 mg (Cabozantinib)
Everest Pharmaceuticals Ltd.
Caboxen (Cabozantinib), a generic Cometriq is a prescription medicine used to treat metastatic medullary thyroid cancer (MTC). Cabozantinib medication blocks the action of a particular enzyme from working which helps to slow or stop the spread of cancer cells. Caboxen is manufactured by Everest Pharma Ltd. in Bangladesh. Cabozantinib has to take orally once a day on an empty stomach (Do not eat for at least 2 hours before and at least 1 hour after taking the dose).
The most common adverse reactions are:
Dizziness, diarrhea, nausea, vomiting, mouth sores, constipation, stomach pain, tiredness, weakness, weight loss, decreased appetite, taste changes, hoarseness, and lightening of hair color.